Max Healthcare Reports Strong Q1 FY26 Growth, Announces Strategic Expansions and Divestments
The announcement details substantial financial performance, significant capacity expansion plans, and strategic portfolio restructuring (divestment and new hospital development). These factors collectively indicate a high impact on the company's future operational scale, financial health, and strategic direction.
The company reported strong financial results with significant year-on-year growth in revenue, EBITDA, and PAT. Strategic initiatives like capacity expansion, successful integration of acquisitions, and divestment of non-aligned assets further contribute to a positive outlook.
Max Healthcare Institute Limited reported a strong start to the financial year, marking its 19th consecutive quarter of year-on-year growth. * Financial Performance (Q1 FY26): * Network gross revenue grew 27% year-on-year to ₹2,574 crores. * Network operating EBITDA increased 23% year-on-year to ₹613 crores, with a margin of 24.9%. * Profit After Tax (PAT) for the Network was ₹345 crores, up 17% year-on-year. * Average occupancy for the Network stood at 76%, while Existing Units achieved over 78% occupancy. * Average Revenue Per Occupied Bed (ARPOB) for the Network was ₹78,000, growing 1% year-on-year. Like-for-like ARPOB for Existing Units grew 5% year-on-year. * Digital revenue reached ₹744 crores, accounting for approximately 29% of overall revenue. * International patient revenue grew 32% year-on-year to ₹208 crores. * Free cash flows for the quarter were ₹389 crores. * Net debt stood at ₹1,755 crores at the end of June 2025. * Strategic Initiatives & Expansions: * The company plans to add approximately 1,000 brownfield and 500 greenfield beds during FY26. * Trial runs have commenced at the new 160-bed brownfield tower at Max Mohali. * The Board approved an agreement-to-lease for a new 130-bed hospital in Dehradun, expected to be commissioned by end of 2028, focusing on advanced oncology services. * Max Healthcare executed a binding term sheet to divest Chitta and Anoopshahr hospitals for ₹40 crores, with completion expected by September 2025. Chitta hospital reported ₹5 crores in revenue and ₹1 crore EBITDA loss in Q1 FY26. * Significant progress is being made on various expansion projects, including 268 beds at Nanavati, 400 beds at Max Smart Saket, and capacity increase at Max Lucknow. * Management Commentary: * Chairman and Managing Director, Abhay Soi, highlighted the strong performance driven by successful integration of recent hospital acquisitions. * CFO Yogesh Sareen mentioned that net debt is expected to increase by ₹400-500 crores by FY26 end, but will remain below 1.0x Net debt-to-EBITDA. * The company noted a one-time donation of ₹12 crores in Q1 FY26 from the Devki Devi Foundation, which impacted EBITDA margin but is not expected to recur. * The company continues to focus on super-specialty care, particularly oncology, and is strategically expanding institutional business where new capacity is being added.
What to do with a filing like this
Max Healthcare Institute Limited filed this with the NSE as a statutory disclosure, categorised under results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Max Healthcare Institute Limited. Read the original for the full detail.